论文部分内容阅读
目的:探讨氟西汀治疗脑卒中后抑郁的临床效果。方法:选取我院2015-02~2016-02收治的100例脑卒中抑郁患者,随机将其分为研究组与对照组,每组50例,对照组给予常规药物治疗,研究组给予氟西汀治疗,对比两组的临床效果,选择Barthel指数、HAMD表评价患者治疗前、治疗第1周、第5周和第10周的疗效。结果:经过治疗,研究组临床各项指标明显优于对照组(P<0.05)。结论:针对脑卒中抑郁患者,选择氟西汀治疗,可明显缩短患者病情,提高肢体功能康复速度,降低残疾程度,提高患者生活质量,值得临床推广运用。
Objective: To investigate the clinical effect of fluoxetine on post-stroke depression. Methods: One hundred patients with stroke who were admitted to our hospital from February 2015 to February 2016 were randomly divided into study group and control group, with 50 cases in each group. The control group was given conventional drug treatment. The study group was given fluoxetine The clinical effects of two groups were compared. The Barthel index was selected. The HAMD table was used to evaluate the effect of treatment before treatment, the first week, the fifth week and the tenth week. Results: After treatment, the clinical indicators in the study group were significantly better than those in the control group (P <0.05). Conclusion: For patients with stroke and depression, the choice of fluoxetine treatment can significantly shorten the patient’s condition, improve physical rehabilitation speed, reduce the degree of disability and improve patient quality of life, worthy of clinical promotion and use.